NLRP3 and hepatocellular carcinoma: The study shows that NLRP3 is upregulated in oxaliplatin‐resistant HCC cells and has a tumor‐intrinsic function in generating an immunosuppressive hepatocellular carcinoma environment by activating IL‐1β and PD‐L1 upregulation.